Use of anxiety-screening questionnaires in patients needing intravitreal anti-VEGF injections may help to identify individuals at risk for elevated pain during the procedure, according to research presented at ARVO 2020.
ARVO
Advertisement
Advertisement
Trending on Modern Retina
1
Retina World Congress 2026: Expanding the DME treatment algorithm beyond anti-VEGF
2
Retina World Congress 2026: Port Delivery System shows durable outcomes at 7 years in neovascular AMD
3
MacTel masquerades: How to spot what others miss
4
Retina World Congress 2026: Dry AMD — Geographic atrophy, photobiomodulation, and the road ahead
5